J0895 HCPCS code: Injection, deferoxamine mesylate, 500 mg
J0895 is the HCPCS Level II code for injection, deferoxamine mesylate, 500 mg. In 2024 Medicare paid an average of $5.92 per service for J0895 across 8,127 services. Its Medicare coverage code is D (Special coverage instructions apply): Medicare covers it when its national or local coverage criteria are met. The NCCI unit limit is 212 per day on DME suppliers. Medicare volume fell 18% from 2022 to 2024 (9,962 to 8,127 services). In 2024, 46 suppliers billed Medicare for J0895 (purchases), serving 55 beneficiaries; California, Texas, New York accounted for 34% of services.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | D — Special coverage instructions apply |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 1992-01-01 |
| Last action effective | 2001-01-01 |
Who bills J0895 (2024)
| Measure | Value |
|---|---|
| Suppliers billing rentals | — |
| Suppliers billing purchases | 46 |
| Referring clinicians | 64 |
| Medicare beneficiaries | 55 |
| States with claims | 17 |
| Share of services in top 3 states (California, Texas, New York) | 34% |
| Year | Suppliers | Beneficiaries |
|---|---|---|
| 2022 | 64 | 83 |
| 2023 | 48 | 60 |
| 2024 | 46 | 55 |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J0895, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 9,962 | 146 | $8.26 | $6.52 |
| 2023 | 7,623 | 138 | $8.34 | $6.55 |
| 2024 | 8,127 | 121 | $7.62 | $5.92 |
States with the most J0895 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| Arizona | 1,580 | $5.92 |
| Texas | 1,478 | $6.06 |
| California | 1,258 | $6.03 |
| Florida | 687 | $6.00 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| DME suppliers | 212 | Clinical: Data |
| outpatient hospital claims | 12 | Prescribing Information |
| practitioner claims | 12 | Prescribing Information |
What changed for J0895
- 1992-01-01: J0895 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J0895?
J0895 is the HCPCS Level II code for injection, deferoxamine mesylate, 500 mg. Short descriptor: "Deferoxamine mesylate inj".
How much does Medicare pay for J0895?
In 2024, the average Medicare payment was $5.92 per service (average allowed $7.62).
Does Medicare cover J0895?
Coverage code D — Special coverage instructions apply. Medicare covers it when its national or local coverage criteria are met.
How many units of J0895 can be billed per day?
212 on DME suppliers; 12 on outpatient hospital claims; 12 on practitioner claims (NCCI medically unlikely edits).
Related J08 codes
- J0800 — Injection, corticotropin, up to 40 units
- J0801 — Injection, corticotropin (acthar gel), up to 40 units
- J0802 — Injection, corticotropin (ani), up to 40 units
- J0833 — Injection, cosyntropin, not otherwise specified, 0.25 mg
- J0834 — Injection, cosyntropin, 0.25 mg
- J0840 — Injection, crotalidae polyvalent immune fab (ovine), up to 1 gram
- J0841 — Injection, crotalidae immune f(ab')2 (equine), 120 mg
- J0850 — Injection, cytomegalovirus immune globulin intravenous (human), per vial
- J0870 — Injection, imetelstat, 1 mg
- J0872 — Injection, daptomycin (xellia), unrefrigerated, not therapeutically equivalent to j0878 or j0873, 1 mg
- J0873 — Injection, daptomycin (xellia), not therapeutically equivalent to j0878 or j0872, 1 mg
- J0874 — Injection, daptomycin (baxter), not therapeutically equivalent to j0878, 1 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J0895
- Watch J0895 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J0895
Sources: CMS HCPCS Level II release October 2025; CMS DMEPOS fee schedule; CMS NCCI MUE tables; CMS Medicare utilization (physician and DME supplier files); CMS Medicare Coverage Database articles. Fees are Medicare allowables, not commercial rates. Not billing or legal advice.